April 16, 2018 in Biotech Industry News Kineta inks $360 million-plus deal with Genentech for chronic pain drug Kineta Inc 3 Like Post Comments Off on Kineta inks $360 million-plus deal with Genentech for chronic pain drug Read More
April 16, 2018 in Biotech Industry News Roche partners with Kineta to develop non-opioid pain therapy Kineta Inc 3 Like Post Comments Off on Roche partners with Kineta to develop non-opioid pain therapy Read More
April 16, 2018 in Biotech Industry News Genentech, Kineta to Partner on Non-Opioid Pain Treatments Kineta Inc 3 Like Post Comments Off on Genentech, Kineta to Partner on Non-Opioid Pain Treatments Read More
April 16, 2018 in Biotech Industry News NAChR average pain drug, Kineta bid bags Genentech deal for as much as $359M+ Kineta Inc 3 Like Post Comments Off on NAChR average pain drug, Kineta bid bags Genentech deal for as much as $359M+ Read More
April 16, 2018 in Biotech Industry News Kineta, Roche’s Genentech strike chronic pain deal Kineta Inc 3 Like Post Comments Off on Kineta, Roche’s Genentech strike chronic pain deal Read More
April 16, 2018 in Biotech Industry News Kineta inks $360 million-plus deal with Genentech for chronic pain drug Kineta Inc 3 Like Post Comments Off on Kineta inks $360 million-plus deal with Genentech for chronic pain drug Read More
March 12, 2018 in Biotech Industry News Non-addictive Cone Snail Therapy Could Help with Chronic Pain, Crains Kineta Inc 0 Like Post Comments Off on Non-addictive Cone Snail Therapy Could Help with Chronic Pain, Crains Read More
September 25, 2017 in Biotech Industry News Seattle biotech company developing non-opioid painkiller, King 5 News Kineta Inc 0 Like Post Comments Off on Seattle biotech company developing non-opioid painkiller, King 5 News Read More
September 6, 2017 in Biotech Industry News Inside Perspectives: Will Immunotherapy Knock Out Cancer? Kineta Inc 0 Like Post Comments Off on Inside Perspectives: Will Immunotherapy Knock Out Cancer? Read More
September 2, 2017 in Biotech Industry News Inside Perspectives on Cancer Immunotherapy: An Interview with Kineta’s Shawn Iadonato Kineta Inc 0 Like Post Comments Off on Inside Perspectives on Cancer Immunotherapy: An Interview with Kineta’s Shawn Iadonato Read More
